請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/77462完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 魏志平 | |
| dc.contributor.author | Jui-Hsin Weng | en |
| dc.contributor.author | 翁瑞昕 | zh_TW |
| dc.date.accessioned | 2021-07-10T22:03:09Z | - |
| dc.date.available | 2021-07-10T22:03:09Z | - |
| dc.date.copyright | 2018-08-23 | |
| dc.date.issued | 2018 | |
| dc.date.submitted | 2018-08-19 | |
| dc.identifier.citation | Ashburn, T. T., & Thor, K. B. (2004). Drug repositioning: Identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery, 3(8), 673.
Cilibrasi, R. L., & Vitanyi, P. M. (2007). The google similarity distance. IEEE Transactions on Knowledge and Data Engineering, 19(3), 370-383. Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006). Sildenafil: From angina to erectile dysfunction to pulmonary hypertension and beyond. Nature Reviews Drug Discovery, 5(8), 689-702. Hristovski, D., Friedman, C., Rindflesch, T. C., & Peterlin, B. (2006). Exploiting semantic relations for literature-based discovery. In AMIA Annual Symposium Proceedings (Vol. 2006, p. 349). American Medical Informatics Association. Kilicoglu, H., Fiszman, M., Rodriguez, A., Shin, D., Ripple, A., & Rindflesch, T. C. (2008). Semantic MEDLINE: A web application for managing the results of PubMed searches. In Proceedings of The Third International Symposium for Semantic Mining in Biomedicine (Vol. 2008, pp. 69-76). Kilicoglu, H., Shin, D., Fiszman, M., Rosemblat, G., & Rindflesch, T. C. (2012). SemMedDB: A PubMed-scale repository of biomedical semantic predications. Bioinformatics, 28(23), 3158-3160. La, M. K., Sedykh, A., Fourches, D., Muratov, E., & Tropsha, A. (2018). Predicting adverse drug effects from literature-and database-mined assertions. Drug Safety. Retrieved from https://link.springer.com/article/10.1007/s40264-018-0688-5 Langley, G. R., Adcock, I. M., Busquet, F., Crofton, K. M., Csernok, E., Giese, C., Heinonen, T., Herrmann, K., Hofmann-Apitius, M., & Landesmann, B. (2017). Towards a 21st-century roadmap for biomedical research and drug discovery: Consensus report and recommendations. Drug Discovery Today, 22(2), 327-339. Lee, K. P. (2017). Literature-based discovery for drug repositioning: A predication ranking approach. Unpublished Master Thesis, Department of Information Management, National Taiwan University, Taipei, Taiwan. Lee, S., Choi, J., Park, K., Song, M., & Lee, D. (2012). Discovering context-specific relationships from biological literature by using multi-level context terms. In BMC Medical Informatics and Decision Making (Vol. 12, No. 1, p. S1). BioMed Central. Majid, R. M., Elayavilli, R. K., Li, D., Prasad, R., & Liu, H. (2015). A new method for prioritizing drug repositioning candidates extracted by literature-based discovery. In 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) (pp. 669-674). IEEE. Majid, R. M., Elayavilli, R. K., Wang, L., Prasad, R., & Liu, H. (2016). Prioritizing adverse drug reaction and drug repositioning candidates generated by literature-based discovery. In Proceedings of the 7th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (pp. 289-296). ACM. Mathur, A., Loskill, P., Hong, S., Lee, J. Y., Marcus, S. G., Dumont, L., . . . Healy, K. E. (2013). Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development. Stem Cell Research & Therapy, 4(1), S14. Price, V. H. (1999). Treatment of hair loss. New England Journal of Medicine, 341(13), 964-973. Rindflesch, T. C., & Fiszman, M. (2003). The interaction of domain knowledge and linguistic structure in natural language processing: Interpreting hypernymic propositions in biomedical text. Journal of Biomedical Informatics, 36(6), 462-477. Rindflesch, T. C., Kilicoglu, H., Fiszman, M., Rosemblat, G., & Shin, D. (2011). Semantic MEDLINE: An advanced information management application for biomedicine. Information Services & Use, 31(1-2), 15-21. Swanson, D. R. (1986). Undiscovered public knowledge. The Library Quarterly, 56(2), 103-118. Swanson, D. R. (1988). Migraine and magnesium: Eleven neglected connections. Perspectives in Biology and Medicine, 31(4), 526-557. Swanson, D. R., & Smalheiser, N. R. (1997). An interactive system for finding complementary literatures: A stimulus to scientific discovery. Artificial Intelligence, 91(2), 183-203. Weeber, M., Klein, H., de Jong‐van den Berg, L. T., & Vos, R. (2001). Using concepts in literature‐based discovery: Simulating Swanson's Raynaud–fish oil and migraine–magnesium discoveries. Journal of The American Society for Information Science and Technology, 52(7), 548-557. Wei, C. P., Chen, K. A., & Chen, L. C. (2014). Mining biomedical literature and ontologies for drug repositioning discovery. In Pacific-Asia Conference on Knowledge Discovery and Data Mining (pp. 373-384). Springer, Cham. Yetisgen-Yildiz, M., & Pratt, W. (2009). A new evaluation methodology for literature-based discovery systems. Journal of Biomedical Informatics, 42(4), 633-643. Zhang, R., Cairelli, M. J., Fiszman, M., Kilicoglu, H., Rindflesch, T. C., Pakhomov, S. V., & Melton, G. B. (2014). Exploiting literature-derived knowledge and semantics to identify potential prostate cancer drugs. Cancer Informatics, 13, CIN-S13889. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/77462 | - |
| dc.description.abstract | 開發新藥物的過程耗時、耗費成本高,且失敗率極高。為解決這個困難,研究人員提出「舊藥新用」的方法,利用原先已通過美國食品藥品監督管理局(FDA)核准的藥物,進行研究並尋找新的適應症,如此作法使藥物開發成本、開發時程大幅減低。
1986年,Swanson 透過尋找醫學文獻之間隱藏的關係來實現舊藥新用,之後的學者大多跟隨 Swanson 所提出的模型來改進研究。先前的研究提出各種不同的方法,例如有些研究使用文字在同一篇文章的出現次數計算關係的權重,另有其他研究在生醫概念網絡當中加入語義關係,而我們的前一篇研究(Lee, 2017)則使用監督式學習的方式,提出路徑重要性的分類模型。在本研究中,我們依循著前一篇研究的方法,將分類模型所使用的特徵加入生醫效應的考量,增加更多有生物醫學意義的特徵值,並且針對某焦點藥物,依照分類的結果計算分數,對其候選疾病進行排序,排序越前面,越可能是該藥物的新適應症。 最後,我們的實驗也證明加入生醫效應相關的特徵能有效提升原先的路徑重要性分類模型,且表現也比傳統的方法佳,可以更有效地找出某焦點藥物的潛在新適應症。 | zh_TW |
| dc.description.abstract | The drug development is an expensive and time-consuming process. Few drugs can be retained from the R&D, clinical trials, to the phase of FDA approval. Researchers begin to find alternative research methods. One of the well-known methods is drug repurposing, the application for approved drugs to new disease indications, which can cut down the cost and reduce the time from the R&D to FDA approval.
In 1986, for drug repurposing, Swanson (1986) proposes a literature-based discovery (LBD) approach for discovering hidden relationships between drugs and diseases through some intermediate biomedical concepts. Afterwards, most of research studies follow Swanson’s model and propose various methods. Some prior studies weight links/paths by term co-occurrence; some add semantic relationships into the biomedical concept network; in our previous study, Lee (2017) proposes the supervised path importance classification method. In this research, we follow the classification method in Lee's study. We take biomedical effects of predicates into account and add additional features, called the effect-based features. Then for a focal drug, the scores for each disease are calculated through the results of path importance classification. According to the scores, we rank the disease candidates. Finally, for finding potential new indications effectively, we prove that by introducing the effect-based features, we improve the performance of the supervised path importance classification model of Lee’s study (2017), and our drug repurposing method also outperforms the traditional methods. | en |
| dc.description.provenance | Made available in DSpace on 2021-07-10T22:03:09Z (GMT). No. of bitstreams: 1 ntu-107-R05725015-1.pdf: 1274312 bytes, checksum: a1fd93d926d472bdbd6cdae96e4e8a54 (MD5) Previous issue date: 2018 | en |
| dc.description.tableofcontents | 誌謝 i
中文摘要 ii Abstract iii Table of Contents iv List of Figures vi List of Tables vii Chapter 1 Introduction 1 1.1 Background 1 1.2 Research Motivation 4 1.3 Research Objective 6 Chapter 2 Literature Review 7 2.1 Concept Selection 7 2.2 Relation Extraction, Link/Path Weighting, and Target Term Ranking 8 Chapter 3 Our Proposed Drug Repurposing Method 12 3.1 Concept Network Construction 13 3.2 Path Importance Classification 14 3.2.1 Link-based Features 15 3.2.2 Intermediate-based Features 17 3.2.3 Predicate-based Features 19 3.2.4 Time-based Feature 20 3.2.5 Effect-based Features 20 3.3 Drug-Disease Discovery 27 Chapter 4 Evaluation of Path Importance Classification 29 4.1 Training Data 29 4.2 Benchmark 30 4.3 Evaluation Procedure and Criteria 31 4.4 Evaluation Results 32 Chapter 5 Evaluation of Drug Repurposing Discovery 34 5.1 Evaluation Design 34 5.2 Evaluation Criteria 36 5.3 Benchmark Methods 37 5.4 Evaluation Results 38 Chapter 6 Conclusion 43 References 45 Appendix A 49 | |
| dc.language.iso | en | |
| dc.subject | 生醫效應 | zh_TW |
| dc.subject | 監督式學習 | zh_TW |
| dc.subject | 舊藥新用 | zh_TW |
| dc.subject | 路徑重要性分類模型 | zh_TW |
| dc.subject | 語義關係 | zh_TW |
| dc.subject | biomedical effect | en |
| dc.subject | drug repurposing | en |
| dc.subject | semantic predication | en |
| dc.subject | supervised learning | en |
| dc.subject | path importance classification | en |
| dc.title | 基於生物醫學文獻及效應改善路徑重要性模型預測藥物新適應症 | zh_TW |
| dc.title | Literature-based Discovery for Drug Repurposing: An Improved Path-importance-based Approach by Considering Predicate Effects | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 106-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 胡雅涵,楊錦生 | |
| dc.subject.keyword | 舊藥新用,語義關係,監督式學習,路徑重要性分類模型,生醫效應, | zh_TW |
| dc.subject.keyword | drug repurposing,semantic predication,supervised learning,path importance classification,biomedical effect, | en |
| dc.relation.page | 50 | |
| dc.identifier.doi | 10.6342/NTU201804022 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2018-08-20 | |
| dc.contributor.author-college | 管理學院 | zh_TW |
| dc.contributor.author-dept | 資訊管理學研究所 | zh_TW |
| 顯示於系所單位: | 資訊管理學系 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-107-R05725015-1.pdf 未授權公開取用 | 1.24 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
